Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients
Clinical trial NCT04603924 · COMPLETED
Trial details
- NCT number
- NCT04603924
- Sponsor
- NeuroBo Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-07
- Primary completion
- 2022-02-16
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.